The weekly litigation news digest is live. Subscribe now

IP Verse

An Inhalable Medicament Comprising Tiotropium - EP3143998

The patent EP3143998 was granted to Teva Pharmaceuticals on May 22, 2019. The application was filed on Dec 6, 2012 under application number EP16185402A. The patent is currently recorded with a legal status of "Revoked".

EP3143998

TEVA PHARMACEUTICALS
Application Number
EP16185402A
Filing Date
Dec 6, 2012
Status
Revoked
Jun 11, 2024
Publication Date
May 22, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
M INNOVATIVE PROPERTIESFeb 21, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP2201934
OPPOSITIONEP2606891
OPPOSITIONEP2793886
OPPOSITIONWO2004054580
OPPOSITIONWO2011061498
OPPOSITIONWO9413262
SEARCHWO2004054580
SEARCHWO2011061498
SEARCHWO9209323

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents